World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
25407
World Ranking
14200
National Ranking
7187

Research.com Recognitions

  • 2008 - Fellow of the American Statistical Association (ASA)

Overview

Thomas J. Herzog is affiliated with the University of Cincinnati in the United States. Their research primarily focuses on medicine, with a significant number of publications in reproductive medicine, oncology, obstetrics and gynecology, surgery, and pulmonary and respiratory medicine.

Their main research topics include ovarian cancer diagnosis and treatment, endometrial and cervical cancer treatments, PARP inhibition in cancer therapy, cancer immunotherapy and biomarkers, intraperitoneal and appendiceal malignancies, cancer genomics and diagnostics, and the economic and financial impacts of cancer.

Notable recent papers authored or co-authored by Thomas J. Herzog include:

  • Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer, 2023, New England Journal of Medicine
  • A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer, 2020, Gynecologic Oncology
  • Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO), 2023, Gynecologic Oncology
  • Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study, 2022, International Journal of Gynecological Cancer
  • The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage, 2021, American Journal of Obstetrics and Gynecology

Frequent publication venues for their work include:

  • Gynecologic Oncology
  • Journal of Clinical Oncology
  • International Journal of Gynecological Cancer
  • American Journal of Obstetrics and Gynecology
  • Gynecologic Oncology Reports

Among their frequent collaborators are:

  • Bradley J. Monk
  • Robert L. Coleman
  • David M. O'Malley
  • Kathleen N. Moore
  • Brian M. Slomovitz

Thomas J. Herzog was awarded the title of Fellow of the American Statistical Association (ASA) in 2008.

Best Publications

  • Nationwide trends in the performance of inpatient hysterectomy in the United States

    Jason D. Wright;Thomas J. Herzog;Jennifer Tsui;Cande V. Ananth

  • Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

    Robert L. Coleman;Mark F. Brady;Thomas J. Herzog;Paul Sabbatini

  • Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease

    Jason D. Wright;Cande V. Ananth;Sharyn N. Lewin;William M. Burke

  • Endometrial cancer: A review and current management strategies: Part I

    William M. Burke;William M. Burke;James Orr;Mario Leitao;Emery Salom

  • Latest research and treatment of advanced-stage epithelial ovarian cancer

    Robert L. Coleman;Bradley J. Monk;Anil K. Sood;Thomas J. Herzog

  • Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

    Bradley J. Monk;Thomas J. Herzog;Stanley B. Kaye;Carolyn N. Krasner

  • Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer

    Andreas Du Bois;Anne Floquet;Jae Weon Kim;Jae Weon Kim;Joern Rau

  • Comparative Performance of the 2009 International Federation of Gynecology and Obstetrics' Staging System for Uterine Corpus Cancer.

    Sharyn N. Lewin;Jason D. Wright

  • Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer

    Krishnansu S. Tewari;Robert A. Burger;Danielle Enserro;Barbara M. Norquist

  • Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

    Bradley J. Monk;Andrés Poveda;Ignace Vergote;Francesco Raspagliesi

  • Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.

    Johnathan M. Lancaster;C. Bethan Powell;Noah D. Kauff;Ilana Cass

  • Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

    Devansu Tewari;James J. Java;Ritu Salani;Deborah K. Armstrong

  • Contemporary management of endometrial cancer

    Jason D Wright;Nicanor I Barrena Medel;Jalid Sehouli;Keiichi Fujiwara

  • Prognostic significance of adenocarcinoma histology in women with cervical cancer.

    Vijaya Galic;Thomas J. Herzog;Sharyn N. Lewin;Alfred I. Neugut

  • Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

    Robert L. Coleman;Nick M. Spirtos;Danielle Enserro;Thomas J. Herzog

  • Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers

    Paul J. Goodfellow;Barbara M. Buttin;Thomas J. Herzog;Janet S. Rader

  • Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers.

    Stacia L. Peiffer;Thomas J. Herzog;Doris J. Tribune;David G. Mutch

  • Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer.

    David E. Cohn;Farrokh Dehdashti;Randall K. Gibb;David G. Mutch

  • Recurrent ovarian cancer: how important is it to treat to disease progression?

    Thomas J. Herzog

  • Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease

    Jason D. Wright;Cande V. Anath;Sharyn N. Lewin;William M. Burke

Frequent Co-Authors

Jason D. Wright
Jason D. Wright Columbia University
Bradley J. Monk
Bradley J. Monk University of Arizona
Robert L. Coleman
Robert L. Coleman The University of Texas MD Anderson Cancer Center
Dawn L. Hershman
Dawn L. Hershman Columbia University
Alfred I. Neugut
Alfred I. Neugut Columbia University
Cande V. Ananth
Cande V. Ananth Rutgers, The State University of New Jersey
David G. Mutch
David G. Mutch Washington University in St. Louis
Robert S. Mannel
Robert S. Mannel University of Oklahoma Health Sciences Center
Michael Friedlander
Michael Friedlander University of New South Wales
Kathleen N. Moore
Kathleen N. Moore University of Oklahoma Health Sciences Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

In addition to traditional medical degrees in the USA, students have an array of flexible options through online programs. For those interested in the technology and data side of healthcare, a health information technology online degree teaches skills in managing patient data and information systems, crucial for the digital transformation of healthcare.

If you’re interested in healthcare administration or entry-level medical roles, consider courses focusing on insurance and claims. Many students search for affordable medical billing and coding cost programs to jumpstart a career in this high-demand field.

Nursing remains a sought-after path, and there are many affordable nursing programs available online. For registered nurses who want to advance their practice, cheapest online fnp programs open up opportunities in advanced patient care, often with flexible online study options.

Online degrees in these areas provide accessible routes to stable and rewarding healthcare careers, with options that can suit a range of educational backgrounds and budgets.

Best Scientists Citing Thomas J. Herzog

Trending Scientists